{
  "type": "object",
  "properties": {
    "STUDY_ID": {
      "type": ["integer"],
      "description": "Unique participant identifier",
      "x-description": "Unique participant identifier in the Generations Study. Present in all source datasets as CancerRegistry.STUDY_ID, FlaggingCancers.StudyID, HistoPath_BrCa.StudyID, and HistoPath_OvCa.StudyID. Values are identical across sources and serve as the primary key to link records between datasets. No transformation or source prioritisation required.",
      "x-sourcePriority": [
        "CancerRegistry.STUDY_ID",
        "FlaggingCancers.StudyID",
        "HistoPath_BrCa.StudyID",
        "HistoPath_OvCa.StudyID"
      ],
      "minimum": 0,
      "maximum": 499994
    },
    "TUMOUR_ID": {
      "type": ["number"],
      "description": "Unique identifier for each tumour (one participant may have several).",
      "x-description": "Tumour-specific identifier. A participant may have multiple tumours, each with its own TUMOUR_ID. Provided directly in CancerRegistry.TUMOURID or FlaggingCancers.TumourID. Pathology datasets (HistoPath_BrCa, HistoPath_OvCa) do not include a universal tumour ID, only tumour-level details (e.g., count, site, laterality, size, grade, stage). When integrating, use CancerRegistry.TUMOURID (or FlaggingCancers.TumourID if registry ID is unavailable) as the primary source. Link pathology tumours to registry/flagging tumours when the pathology DATEKEY (best pathology date: DateSpecimenTaken → DateSpecimenReceived) is within ±90 days of the registry diagnosis date (DIAGNOSISDATEBEST) or flagging diagnosis date, and site/laterality/morphology are compatible. If pathology tumours cannot be linked, generate a synthetic ID in the format SYN-{STUDY_ID}-{DATEKEY}-{SITE3}-{LAT}-{SEQ}, where SITE3 is ICD-10 3-char (or UNK), LAT is laterality (L|R|M|B|U), and SEQ is a 2-digit sequence per participant/date/site/side. Group pathology records into one tumour if within 90 days, same site/laterality, and morphology-compatible. If an official ID later becomes available, replace the synthetic ID and maintain a lookup table that records the relationship between the two identifyers .",
      "x-sourcePriority": [
        "CancerRegistry.TUMOURID",
        "FlaggingCancers.TumourID"
      ]
    },
    "DIAGNOSIS_DATE": {
      "type": ["string", "null"],
      "format": "date",
      "description": "Best estimate of tumour diagnosis date (per tumour).",
      "x-description": "Best estimate of the tumour diagnosis date (YYYY-MM-DD). Each participant may have multiple diagnosis dates, one per distinct tumour (TUMOUR_ID). Source priority: 1) CancerRegistry.DIAGNOSISDATEBEST; 2) Pathology reports — for breast use HistoPath_BrCa in this order: Coredat, DateSpecimenTaken, DateSpecimenReceived, ReportDat; for ovarian use HistoPath_OvCa in the same order: Coredat, DateSpecimenTaken, DateSpecimenReceived, ReportDat; 3) FlaggingCancers.DCancer; ",
      "x-sourcePriority": [
        "CancerRegistry.DIAGNOSISDATEBEST",
        "HistoPath_BrCa.CoreDat",
        "HistoPath_BrCa.DateSpecimenTaken",
        "HistoPath_BrCa.DateSpecimenReceived",
        "HistoPath_BrCa.ReportDat",
        "HistoPath_OvCa.CoreDat",
        "HistoPath_OvCa.DateSpecimenTaken",
        "HistoPath_OvCa.DateSpecimenReceived",
        "HistoPath_OvCa.ReportDat",
        "FlaggingCancers.DCancer"
      ]
    },
    "AGE_AT_DIAGNOSIS": {
      "type": ["number"],
      "description": "Age of the patient when they were diagnosed with the tumour in years. (per tumour).",
      "x-description": "Age in whole years at diagnosis, calculated separately for each tumour (TUMOUR_ID) only if not available in CancerRegistry.AGE. Derived as floor((DIAGNOSIS_DATE – CancerRegistry.BIRTHDATEBEST) / 365.25).",
      "x-sourcePriority": [
        "CancerRegistry.AGE"
      ],
      "minimum": 0,
      "maximum": 200
    },
    "ICD_CODE": {
      "type": ["string", "null"],
      "description": "ICD-10-O2 site code (4-character) for tumour site.",
      "x-description": "Primary ICD-10-O2 site code (4-character) describing the site of origin of the neoplasm. Source priority: 1) CancerRegistry.SITE_ICD10_O2 (\"Describes site of origin of the neoplasm\"); 2) FlaggingCancers.CancerICD (\"Cancer ICD code\"). Use the code as provided by the source without recoding. This field is per tumour (TUMOUR_ID).",
      "x-sourcePriority": [
        "CancerRegistry.SITE_ICD10_O2",
        "FlaggingCancers.CancerICD"
      ],
      "maxLength": 4
    },
    "ICD_CODE_3CHAR": {
      "type": ["string", "null"],
      "description": "ICD-10-O2 site code (3-character, broader category).",
      "x-description": "Three-character ICD-10-O2 site code describing the site of origin of the neoplasm. Source priority: 1) CancerRegistry.SITE_ICD10_O2_3CHAR (preferred, standard ICD-10-O2); 2) CancerRegistry.SITE_CODED_3CHAR (fallback for legacy/compatibility); 3) Derived as the first three characters of ICD_CODE (from CancerRegistry.SITE_ICD10_O2 or FlaggingCancers.CancerICD). Null if not available.",
      "x-sourcePriority": [
        "CancerRegistry.SITE_ICD10_O2_3CHAR",
        "CancerRegistry.SITE_CODED_3CHAR"
      ],
      "maxLength": 4
    },
    "MORPH_CODE": {
      "type": ["number", "null"],
      "description": "ICD-O morphology code (tumour histology/behaviour).",
      "x-description": "ICD-O morphology code describing the histological type/behaviour of the tumour (as provided by the source; may include the behaviour suffix, e.g., \"/2\", \"/3\"). Per tumour (TUMOUR_ID). Source priority: 1) CancerRegistry.MORPH_ICD10_O2 (preferred); 2) CancerRegistry.MORPH_CODED (fallback); 3) HistoPath_BrCa.ICDMorphologyCode. Store the code exactly as provided (no recoding).",
      "x-sourcePriority": [
        "CancerRegistry.MORPH_ICD10_O2",
        "CancerRegistry.MORPH_CODED",
        "HistoPath_BrCa.ICDMorphologyCode"
      ],
      "minimum": 8000,
      "maximum": 9999
    },
    "HISTOLOGY_CODE": {
      "type": ["number", "null"],  
      "description": "Histology code - combines the morphology and behaviour codes.",
      "x-description": "ICD-O Histology code describing the combination of morphology and behaviour of the tumour (as provided by the source; may include the behaviour suffix, e.g., \"/2\", \"/3\"). Per tumour (TUMOUR_ID). Source priority: 1) CancerRegistry.HISTOLOGY_CODED (preferred); 2)FlaggingCancers.Histology. Store the code exactly as provided (no recoding).",
      "x-sourcePriority": [
        "CancerRegistry.HISTOLOGY_CODED",
        "FlaggingCancers.Histology"
      ]
      },
    "SITE": {
      "type": ["string", "null"],
      "description": "Text description of anatomical site (from registry or pathology).",
      "x-description": "Text description of anatomic site.  Source priority: 1) CancerRegistry.SITE_CODED_DESC; 2) For ovarian cancers only, HistoPath_OvCa.Primary_Site; else null.",
      "x-sourcePriority": [
        "CancerRegistry.SITE_CODED_DESC",
        "HistoPath_OvCa.Primary_Site"
      ]
    },
    "GRADE": {
      "type": ["string"],
      "description": "Tumour histological grade (harmonised, per registry coding).",
      "x-description": "Tumour histological grade (harmonised to Cancer Registry coding). Source priority: 1) For breast: HistoPath_BrCa.InvasiveGrade, mapped to Cancer Registry format (InvasiveGrade 1→G1, 2→G2, 3→G3); 2) For ovarian: HistoPath_OvCa.Grade_I_II_III, mapped to Cancer Registry format (I→G1, II→G2, III→G3); 3) CancerRegistry.GRADE (retain registry codes exactly: GX, G0–G7, GL/GH/GI/G) if pathology grade is not available. All pathology- and registry-derived values must be harmonised into the Cancer Registry coding system; pathology values take precedence when present.",
      "x-sourcePriority": [
        "HistoPath_BrCa.InvasiveGrade",
        "HistoPath_OvCa.Grade_I_II_III",
        "CancerRegistry.GRADE"
      ],
      "enum": ["GX", "G0", "G1", "G2", "G3", "G4", "G5", "G6", "G7", "GL", "GH", "GI", "G"],
      "enumDescriptions": [
        "GX : Grade of differentiation is not appropriate or cannot be assessed",
        "G0 : Borderline malignancy",
        "G1 : Well differentiated",
        "G2 : Moderately differentiated",
        "G3 : Poorly differentiated",
        "G4 : Undifferentiated / anaplastic",
        "G5 : T Cell",
        "G6 : B Cell",
        "G7 : Null cell",
        "GL: ",
        "GH: ",
        "GI: ",
        "G:"
      ]
    },
    "TUMOUR_SIZE": {
      "type": ["number", "null"],
      "description": "Largest tumour dimension in millimetres.",
      "x-description": "Largest tumour dimension in millimetres (harmonised to Cancer Registry coding). Source priority: 1) Pathology: Breast (HistoPath_BrCa.SizeInvasiveTumour; if invasive size missing and DCIS only, use HistoPath_BrCa.SizeDCISOnly). 2) CancerRegistry.TUMOURSIZE. Pathology values take precedence when available; record numeric size only, null if text/ambiguous.",
      "x-sourcePriority": [
        "HistoPath_BrCa.SizeInvasiveTumour",
        "HistoPath_BrCa.SizeDCISOnly",
        "CancerRegistry.TUMOURSIZE"
      ]
    },
    "NODES_TOTAL": {
      "type": ["number", "null"],
      "description": "Number of lymph nodes examined.",
      "x-description": "Total number of local/regional lymph nodes examined (per tumour, TUMOUR_ID). Source priority: 1) Breast pathology: HistoPath_BrCa.AxillaryNodesTotal + HistoPath_BrCa.OtherNodesTotal (sum; treat nulls as 0 only if at least one component is non-null); 2) CancerRegistry.NODESINVOLVED — described in the registry schema as the \"number of local and regional nodes examined.\" Ovarian pathology does not provide node counts. Store as an integer; null if unavailable.",
      "x-sourcePriority": [
        "HistoPath_BrCa.AxillaryNodesTotal",
        "HistoPath_BrCa.OtherNodesTotal",
        "CancerRegistry.NODESINVOLVED"
      ]
    },
    "NODES_POSITIVE": {
      "type": ["number", "null"],
      "description": "Number of lymph nodes positive for metastasis.",
      "x-description": "Number of local/regional lymph nodes positive for metastasis (per tumour, TUMOUR_ID). Source priority: 1) Breast pathology: HistoPath_BrCa.AxillaryNodesPositive + HistoPath_BrCa.OtherNodesPositive (sum; treat nulls as 0 only if at least one component is non-null); 2) CancerRegistry.NODESEXCISED — described in the registry schema as the \"number of local and regional nodes reported as being positive.\" Ovarian pathology does not provide node counts. Store as an integer; null if unavailable.",
      "x-sourcePriority": [
        "HistoPath_BrCa.AxillaryNodesPositive",
        "HistoPath_BrCa.OtherNodesPositive",
        "CancerRegistry.NODESEXCISED"
      ]
    },
    "STAGE": {
      "type": ["string", "null"],
      "description": "Best overall tumour stage.",
      "x-description": "Best tumour stage at diagnosis (harmonised to Cancer Registry coding). Source priority: 1) CancerRegistry.STAGE_BEST. Pathology-derived staging takes precedence when available; all values must be expressed in the Cancer Registry coding system.; 2) Pathology staging (Breast: HistoPath_BrCa.Tstage, HistoPath_BrCa.NStage, HistoPath_BrCa.Mstage; Ovarian: HistoPath_OvCa.Stage_Best or FIGO if available), mapped to Cancer Registry stage format; ",
      "x-sourcePriority": [
        "CancerRegistry.STAGE_BEST",
        "HistoPath_OvCa.Stage_Best",
        "HistoPath_OvCa.Stage_FIGO",
        "HistoPath_BrCa.Tstage",
        "HistoPath_BrCa.NStage",
        "HistoPath_BrCa.Mstage"        
      ],
      "enum": ["0", "0A", "0B", "0C", "0IS", "1", "1C3", "1A", "1A1", "1A2", "1A3", "1AE", "1AES", "1AEX", "1AEXS", "1AS", "1AX", "1B", "1B1", "1B2", "1BE", "1BES", "1BEX", "1BS", "1BX", "1C", "1C1", "1C2", "IC3", "1E", "1ES", "1EX", "1S", "1X", "1XS", "2", "2A", "2A1", "2A2", "2AE", "2AES", "2AEX", "2AS", "2AX", "2B", "2BE", "2BEX", "2BS", "2BX", "2C", "2E", "2ES", "2EX", "2S", "2X", "3", "3A", "3A1", "3A1i", "3A1ii", "3A2", "3AE", "3AES", "3AEX", "3AS", "3AX", "3B", "3BE", "3BES", "3BEX", "3BEXS", "3BS", "3BX", "3BXS", "3C", "3C1", "3C2", "3D", "3E", "3ES", "3EX", "3S", "3X", "3XS", "4", "4A", "4AE", "4AES", "4AEX", "4AEXS", "4AS", "4AX", "4AXS", "4B", "4BE", "4BES", "4BEX", "4BEXS", "4BS", "4BX", "4BXS", "4BS", "4BX", "4BXS", "4C", "4E", "4ES", "4EX", "4EXS", "4S", "4X", "A", "B", "C", "5", "6", "?", "U", "X", null],
      "enumDescriptions": [
        "Stage 0: 0, 0A, 0B, 0C, 0IS",
        "Stage 1: 1, 1A, 1A1, 1A2, 1A3, 1AE, 1AES, 1AEX, 1AEXS, 1AS, 1AX, 1B, 1B1, 1B2, 1BE, 1BES, 1BEX, 1BS, 1BX, 1C, 1C1, 1C2, IC3, 1E, 1ES, 1EX, 1S, 1X, 1XS",
        "Stage 2: 2, 2A, 2A1, 2A2, 2AE, 2AES, 2AEX, 2AS, 2AX, 2B, 2BE, 2BEX, 2BS, 2BX, 2C, 2E, 2ES, 2EX, 2S, 2X",
        "Stage 3: 3, 3A, 3A1, 3A1i, 3A1ii, 3A2, 3AE, 3AES, 3AEX, 3AS, 3AX, 3B, 3BE, 3BES, 3BEX, 3BEXS, 3BS, 3BX, 3BXS, 3C, 3C1, 3C2, 3D,  3E, 3ES, 3EX, 3S, 3X, 3XS",
        "Stage 4: 4, 4A, 4AE, 4AES, 4AEX, 4AEXS, 4AS, 4AX, 4AXS, 4B, 4BE, 4BES, 4BEX, 4BEXS, 4BS, 4BX, 4BXS, 4BS, 4BX, 4BXS, 4C, 4E, 4ES, 4EX, 4EXS, 4S, 4X",
        "A, B, C: RaiBinet stage",
        "5: Outdated or invalid code",
        "6: not stageable",
        "?: insufficient information",
        "U: unstageable",
        "X: not staged"
      ]
    },
    "ER_STATUS": {
      "type": ["string", "null"],
      "description": "Oestrogen receptor status (breast tumours only).",
      "x-description": "Oestrogen receptor (ER) status (harmonised to Cancer Registry coding). Source priority: 1) HistoPath_BrCa.ER_Status (map NP → X; retain P/N; map borderline if present to B); 2) CancerRegistry.ER_STATUS (retain registry codes: P/N/B/X/U). Pathology values take precedence when available; all values must be expressed in the Cancer Registry coding system.",
      "x-sourcePriority": [
        "CancerRegistry.ER_STATUS",
        "HistoPath_BrCa.ER_Status"
      ],
      "enum": ["N", "P", "X", "B", "U", null],
      "enumDescriptions": ["N: Negative", "P: Positive", "X: Not Performed", "B: Borderline", "U:", "null: Not applicable"]
    },
    "PR_STATUS": {
      "type": ["string", "null"],
      "description": "Progesterone receptor status (breast tumours only).",
      "x-description": "Progesterone receptor (PR) status (harmonised to Cancer Registry coding). Source priority: 1) HistoPath_BrCa.PR_Status (map NP → X; retain P/N; map borderline if present to B); 2) CancerRegistry.PR_STATUS (retain registry codes: P/N/B/X/U). Pathology values take precedence when available; all values must be expressed in the Cancer Registry coding system.",
      "x-sourcePriority": [
        "CancerRegistry.PR_STATUS",
        "HistoPath_BrCa.PR_Status"
      ],
      "enum": ["N", "P", "X", "B", "U", null],
      "enumDescriptions": ["N: Negative", "P: Positive", "X: Not Performed", "B : Borderline", "U: ", "null: Not applicable"]
    },
    "HER2_STATUS": {
      "type": ["string", "null"],
      "description": "HER2 receptor status (breast tumours only).",
      "x-description": "HER2 receptor status (harmonised to Cancer Registry coding). Source priority: 1) HistoPath_BrCa.HER2_Status (map NP → X; retain P/N/B); 2) CancerRegistry.HER2_STATUS (retain registry codes: P/N/B/X/U). If both IHC and FISH are available in pathology, use the definitive integrated result; pathology values take precedence when available; all values must be expressed in the Cancer Registry coding system.",
      "x-sourcePriority": [
        "CancerRegistry.HER2_STATUS",
        "HistoPath_BrCa.HER2_Status"
      ],
      "enum": ["N", "P", "X", "B", "U", null],
      "enumDescriptions": ["N: Negative", "P: Positive", "X: Not Performed", "B: Borderline", "U:", "null: Not applicable"]
    },
    "Ki67": {
      "type": ["number", "null"],
      "description": "Ki67 proliferation index (% positive nuclei, breast only).",
      "x-description": "Ki67 proliferation index (% of tumour nuclei positive, recorded as an integer 1–100). Source: HistoPath_BrCa.Ki67 only. Pathology values are stored as-is; record as a numeric percentage without the % sign. Null if not reported. Each value is per tumour (TUMOUR_ID).",
      "x-sourcePriority": [
        "HistoPath_BrCa.Ki67"
      ],
      "minimum": 1,
      "maximum": 100
    },
    "SCREEN_DETECTED": {
      "type": ["string", "null"],
      "description": "Whether tumour was screen-detected (Y/N/8/9).",
      "x-description": "Whether the tumour was detected via a screening programme. Source priority: 1) CancerRegistry.FINAL_ROUTE — set 'Y' if FINAL_ROUTE = 'Screening'; set 'N' if FINAL_ROUTE = any non-screening route; set '9' if unknown. 2) HistoPath_BrCa.ScreenDetected (Y/N/NK → map NK to '9'). Allowed values: 'Y' (Yes), 'N' (No), '8' (Not applicable), '9' (Not known).",
      "x-sourcePriority": [
        "CancerRegistry.FINAL_ROUTE",
        "HistoPath_BrCa.ScreenDetected"
      ],
      "enum": ["N", "Y", "8", "9", null],
      "enumDescriptions": ["N : No", "Y : Yes", "8 : Not applicable", "9 : Not known"]
    },
    "LATERALITY": {
      "type": ["string", "null"],
      "description": "Side of body affected (left, right, bilateral, unknown).",
      "x-description": "Laterality of the tumour (per tumour, TUMOUR_ID). Source priority: 1) HistoPath_BrCa.Side (map L/R as-is, U → '9'); 2) CancerRegistry.LATERALITY (retain registry codes: L, R, M, B, 8, 9). Pathology values take precedence when available; harmonise all values to registry coding.",
      "x-sourcePriority": [
        "CancerRegistry.LATERALITY",
        "HistoPath_BrCa.Side"        
      ],
      "enum": ["L", "R", "M", "B", "8", "9"],
      "enumDescriptions": ["L: Left", "R: Right", "M: Midline", "B: Bilateral", "8: Not applicable", "9: Not Known"]
    },
    "T_STAGE": {
      "type": ["string", "null"],
      "description": "TNM T component (tumor size).",
      "x-description": "Tumour TNM T stage (per tumour, TUMOUR_ID). Source priority: 1) HistoPath_BrCa.Tstage; 2) CancerRegistry.T_BEST. Pathology values take precedence when available; harmonise to Cancer Registry coding. For ovarian cancers, use STAGE rather than TNM.",
      "x-sourcePriority": [
        "HistoPath_BrCa.Tstage",
        "CancerRegistry.T_BEST"
      ],
      "pattern": "(?i)^(NA|[ycp]{1,2}|[ycp]{0,2}T?[0-4]?[a-dA-DcCmi]{0,3}|[ycp]{0,2}T?is|G\\d{1,2}\\s*T[0-4]?[a-dA-D]{0,2}|\\d{1,2}[a-dA-D]?|[ycp]{0,2}T[0-9a-zA-Z`']{0,4}|[ycp]{0,2}T[0-9a-zA-Z]{0,4}[\\s-]*\\([^)]+\\)|[ycp]{0,2}T[0-9a-zA-Z]{0,4}/[ycp]{0,2}T[0-9a-zA-Z]{0,4}|[ycp]{0,2}T[0-9a-zA-Z]{0,4}[\\s`'()\\-]*[a-zA-Z0-9]*)$"
    },
    "N_STAGE": {
      "type": ["string", "null"],
      "description": "TNM N component (lymph node involvement).",
      "x-description": "Tumour TNM N stage (per tumour, TUMOUR_ID). Source priority: 1) HistoPath_BrCa.NStage; 2) CancerRegistry.N_BEST. Pathology values take precedence when available; harmonise to Cancer Registry coding. For ovarian cancers, use STAGE rather than TNM.",
      "x-sourcePriority": [
        "HistoPath_BrCa.NStage",
        "CancerRegistry.N_BEST"
      ],
      "pattern": "(?ix)^(y)?(c|p|L1|pT)?(NX|N[0O]|T[0O]|TN[0O]|N1(?:mi|a|b|c|biv|mic|mc|osna)?(?:/\\d+)?|N2[ab]?|N3[abc]?|NIbiv|N)?\\s*(i\\+)?((?:\\([^)]+(\\)|$))*)((?:\\([^)]+\\))*)[\\w/+±\\-]*$"
    },
    "M_STAGE": {
      "type": ["string", "null"],
      "description": "TNM M component (distal metastasis)",
      "x-description": "Tumour TNM M stage (per tumour, TUMOUR_ID). Source priority: 1) HistoPath_BrCa.Mstage; 2) CancerRegistry.M_BEST. Pathology values take precedence when available; harmonise to Cancer Registry coding. For ovarian cancers, use STAGE rather than TNM.",
      "x-sourcePriority": [
        "HistoPath_BrCa.Mstage",
        "CancerRegistry.M_BEST"
      ],
      "pattern": "^(c|p)?(MX|M0|M0\\(i\\+\\)|M1)$"
    },
    "SOURCE": {
      "type": ["string", "null"],
      "description": "Data sources used for tumour record.",
      "x-description": "Audit trail of data sources used for this tumour record. For each variable, record the source dataset (e.g., Registry, Pathology_BrCa, Pathology_OvCa, Flagging). At the record level, summarise as a comma-separated list of unique sources. Multiple sources may apply.",
      "x-sourcePriority": []
    },
    "DATE_CREATED": {
      "type": ["string", "null"],
      "format": "date",
      "description": "Date the casummary record was created.",
      "x-description": "Timestamp (YYYY-MM-DD or date-time) when this casummary record was created. Set by the integration process; not sourced from clinical data.",
      "x-sourcePriority": []
    },
    "COMMENTS": {
      "type": ["string", "null"],
      "description": "Free-text notes about tumour record.",
      "x-description": "Free-text notes about data integration decisions or anomalies for this tumour record.",
      "x-sourcePriority": []
    },
    "STAGE_FIGO": {
      "type": ["string", "null"],
      "description": "FIGO stage (ovarian/fallopian/peritoneal tumours only).",
      "x-description": "FIGO stage at diagnosis (ovarian, fallopian tube, or primary peritoneal tumours only; per tumour, TUMOUR_ID). Source: HistoPath_OvCa.Stage_FIGO (pathology-only). Store verbatim as reported (e.e., I, IA–IC, II, IIIA–IIIC, IV, IVA–IVB). Null for non-ovarian tumours. If multiple pathology records exist for the same tumour episode, use the most definitive value from within the 90-day grouping window. This field is not harmonised to registry STAGE; it complements STAGE.",
      "x-sourcePriority": [
        "HistoPath_OvCa.Stage_FIGO"
      ]
    },
    "BENIGN_TUMOUR": {
      "type": ["number", "null"],
      "description": "Indicator if ovarian tumour was benign (0 = No, 1 = Yes).",
      "x-description": "Indicator of whether the ovarian tumour was benign (per tumour, TUMOUR_ID). Source: HistoPath_OvCa.Benign_Tumour. Type: number or null. Expected coding: 0 = No, 1 = Yes; null if not applicable. Variable only applies to ovarian tumours; null for breast and other sites.",
      "x-sourcePriority": [
        "HistoPath_OvCa.Benign_Tumour"
      ]
    }
  }
}